Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Multiple Sclerosis

  Free Subscription


5 Mult Scler
3 Neurol Clin Pract
1 Neurology
1 Neurosci Lett
2 PLoS One
1 Rev Neurol (Paris)

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Mult Scler

  1. GIORDANA MT, Cavalla P, Uccelli A, Laroni A, et al
    Overexpression of sphingosine-1-phosphate receptors on reactive astrocytes drives neuropathology of multiple sclerosis rebound after fingolimod discontinuation.
    Mult Scler. 2018 Apr 1:1352458518763095. doi: 10.1177/1352458518763095.
    PubMed     Text format     Abstract available

  2. HARMEL P, Schlunk F, Harms L
    Fulminant rebound of relapsing-remitting multiple sclerosis after discontinuation of dimethyl fumarate: A case report.
    Mult Scler. 2018 Apr 1:1352458517741191. doi: 10.1177/1352458517741191.
    PubMed     Text format     Abstract available

    Rebound disease in multiple sclerosis.
    Mult Scler. 2018 Apr 1:1352458518772913. doi: 10.1177/1352458518772913.
    PubMed     Text format    

  4. FROEHLICH A, Schmidt S, Landsberg J, Bieber T, et al
    Spontaneous regression of tumor-stage cutaneous T-cell lymphoma in a multiple sclerosis patient after discontinuing fingolimod.
    Mult Scler. 2018 May 1:1352458518774444. doi: 10.1177/1352458518774444.
    PubMed     Text format    

  5. GIOVANNONI G, Soelberg Sorensen P, Cook S, Rammohan KW, et al
    Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study.
    Mult Scler. 2018 Apr 1:1352458518771875. doi: 10.1177/1352458518771875.
    PubMed     Text format     Abstract available

    Neurol Clin Pract

  6. LONGBRAKE EE, Kantor D, Pawate S, Bradshaw MJ, et al
    Effectiveness of alternative dose fingolimod for multiple sclerosis.
    Neurol Clin Pract. 2018;8:102-107.
    PubMed     Text format     Abstract available

  7. KAISEY M, Sicotte N, Giesser B
    Multiple sclerosis management and reproductive changes: A guide for general neurologists.
    Neurol Clin Pract. 2018;8:142-147.
    PubMed     Text format     Abstract available

  8. BRANDAO DE PAIVA AR, Pucci Filho CR, Porto AM, Feltrin FS, et al
    When multiple sclerosis and X-linked adrenoleukodystrophy are tangled: A challenging case.
    Neurol Clin Pract. 2018;8:156-158.
    PubMed     Text format    


  9. FRANKLIN GM, McDonnell G
    Free health care, great data, and new clues on multiple sclerosis.
    Neurology. 2018 May 2. pii: WNL.0000000000005593.
    PubMed     Text format    

    Neurosci Lett

  10. MERCADO F, Almanza A, Rubio N, Soto E, et al
    Kir 4.1 inward rectifier potassium channel is upregulated in astrocytes in a murine multiple sclerosis model.
    Neurosci Lett. 2018;677:88-93.
    PubMed     Text format     Abstract available

    PLoS One

  11. Correction: Empirical mode decomposition processing to improve multifocal-visual-evoked-potential signal analysis in multiple sclerosis.
    PLoS One. 2018;13:e0196928.
    PubMed     Text format     Abstract available

  12. STORM FA, Nair KPS, Clarke AJ, Van der Meulen JM, et al
    Free-living and laboratory gait characteristics in patients with multiple sclerosis.
    PLoS One. 2018;13:e0196463.
    PubMed     Text format     Abstract available

    Rev Neurol (Paris)

  13. BIOTTI D, Ciron J
    First-line therapy in relapsing remitting multiple sclerosis.
    Rev Neurol (Paris). 2018 Apr 24. pii: S0035-3787(18)30007.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.